| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
|---|
| Outline of Final Research Achievements |
The present study was designed to delineate the possible involvement of Bcl-2 in the cytoprotective effects of Sig-1R against mitochondria originated apoptosis in cells. We expected that Sig-1R may exert cytoprotective effects against mitochondria oriented stress through regulation of Bcl-2, however our findings indicate that Sig-1R as well as Bcl-2 regulates mitochondria-originated apoptosis through different ways; Sig-1R and Bcl-2 at mitochondria could regulate the caspase pathway and phosphorylation of GSK-3β to protect the cells, respectively.
Sig-1R as an ER chaperone is upregulated to protect cells against long-term stimulation of MOR1C, and sabotage its assigned functions by translocation induced by unexpected stimuli. Thus, Sig-1R is an important molecule in the maintaining the homeostasis and the expression of withdrawal signs in the morphine-adapted state. Our findings indicate that Sig-1R antagonists could be a candidate for the treatment of opioid withdrawal symptoms.
|
